These findings offer a promising new therapeutic strategy for HD
Chemotherapy-induced peripheral neuropathy Four randomized controlled trials (RCTs) have evaluated the use of acetyl-L-carnitine (LC) for the prevention of chemotherapy-induced peripheral neuropathy (CIPN)
[PMID: 15036959] PubMed record related to this compound for laboratory literature review
Vic hiu r s khc bit gia dng kh (GSH) v dng oxy ha (GSSG), la chn ngun nguyn liu cht lng t Nht Bn v phn bit sn phm chnh hng s gip bn a ra quyt nh ng n
Additionally, they exhibit a repertoire of cell surface markers, including SDC3/4, 71 integrin, CD34, c-Met, NCAM, VCAM1, N-cadherin, M-cadherin, CXCR4, CALCR, and CAV1
Mol Neurodegener 12:122 Masrori P, Van Damme P (2020) Amyotrophic lateral sclerosis: a clinical review